Skip to main content
Premium Trial:

Request an Annual Quote

Animals Protest NHGRI Priorities


By Martha J. Heil

BETHESDA, MD — Responding to an NHGRI report naming six “high-priority” organisms for genome sequencing, thousands of animals took to the NIH campus here today to protest.

The animals, including the Xenopus frog, pig, and duck-billed platypus, insisted that the selection of some organisms over others amounted to genetic discrimination. “It’s bad enough that we are burdened with being the universal metaphor for everything filthy,” said the pig with a snort.

Protesters sang, croaked, buzzed. squealed, and threw their own feces at researchers entering the NHGRI labs. "No wonder we''re going mad," said the cow, threatening to hold a milk strike.

"Who ever heard of Tetrahymena thermophila?" said the cat. "How did that spineless wonder make it to the top?"

Not all animals, though, saw sequencing as desirable. The chicken, listed as a high priority for sequencing in the report, was seen trying to escape amidst the turmoil. "I''m just too afraid," she said.

NHGRI said that it would consider adding other animals to the sequencing list in the future. But animal protesters said that the institute did not give clear reasons why some animals were chosed over others.

"Our name is synonymous with ''animal used in research,''" said the guinea pig. "But I guess if you''re Craig Venter''s show poodle, you move to the top of the list."

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.